Anti ‐PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease
ConclusionsOur findings confirmed that 6D11 has a therapeutic effect in APP/PS1 transgenic AD mouse model and A β-induced AD cell model, and the effect exerted via increase of neurogenesis and cell differentiation by transduction of Aβ peptide signal.
Source: Brain and Behavior - Category: Neurology Authors: Ruolin Li,
Ming Ren,
Yingxin Yu Tags: ORIGINAL ARTICLE Source Type: research
More News: Alzheimer's | Brain | Learning | Neurology | Speech and Language Disorders | Stem Cell Therapy | Stem Cells | Study | Universities & Medical Training